Cancer Advisor

Home  ›  Cancer Academy & Protocols Library  ›  Systems Oncology Series  ›  The New Blueprint for Cancer Treatment Narrative Review · Journal-Format Edition Systems Oncology Series · Part 3 A structured narrative evidence review, formatted for transparency of methods, sourcing, and evidence grading. Abstract Background: Checkpoint immunotherapy, CAR-T cell therapy, targeted therapy, antibody-drug conjugates, and now personalized mRNA cancer vaccines have each produced genuine, sometimes durable, benefit. Yet outcomes for advanced and metastatic disease remain limited chiefly by two intertwined biological properties that no single breakthrough has solved: tumor heterogeneity and phenotypic (lineage) plasticity . Objective: To synthesize current and emerging evidence on treatment-design strategies built specifically to counter heterogeneity and plasticity, and to organize them into a coherent framework for how cancer treatment is bei...

Quick Answer: This framework merges OneDayMD's I-PREVENT Cancer Protocol with Dr. Paul Marik and Dr. Justus Hope's ROOT Protocol into a single five-layer system. Layer 1 is diet, metabolic health, and lifestyle — the original I-PREVENT foundation. Layers 2–3 are food-derived nutraceuticals (EGCG, curcumin, vitamin D3, omega-3, berberine, sulforaphane, vitamin C, magnesium, zinc, garlic, melatonin, and more), graded from strongest human-trial evidence to broader supporting data. Layer 4 is an optional Aged Garlic Extract upgrade. Layer 5 is Root 9 — the prescription drugs celecoxib, ivermectin, and mebendazole — which both authors scope strictly to people with confirmed hereditary cancer syndromes under specialist supervision, not general use. This is a prevention framework for healthy adults, not a cancer treatment protocol. Medically reviewed and updated by the OneDayMD Editorial Team | Merged framework published July 12, 2026 | Synthesizes and supersedes two ...